• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接受化疗后残余肿瘤切除(PC-RPLND)的睾丸癌患者中,主要血管手术的术前临床和影像学预测因素。

Preoperative clinical and radiographic predictors of major vascular surgery in patients with testicular cancer undergoing post-chemotherapy residual tumor resection (PC-RPLND).

机构信息

Department of Urology and Pediatric Urology, Saarland University Medical Center, Universitätsklinikum des Saarlandes, Saarland University, 66421, Homburg/Saar, Germany.

Division of Experimental Oncology/Unit of Urology, Department of Urology, URI, IRCCS San Raffaele Scientific Hospital, Milan, Italy.

出版信息

World J Urol. 2022 Feb;40(2):349-354. doi: 10.1007/s00345-021-03870-8. Epub 2021 Nov 3.

DOI:10.1007/s00345-021-03870-8
PMID:34731264
Abstract

PURPOSE

To evaluate the probability to correctly predict major vascular surgery (MVS) in patients undergoing postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for testicular cancer.

METHODS

From a database of 504 RPLNDs performed in 434 patients (2008-2018), 78 patients submitted to PC-RPLND for non-seminoma germ-cell cancer after cisplatin-based chemotherapy with available preoperative CT scans were identified. Second PC-PLNDs (Re-Dos), salvage RPLNDs, or RPLNDs for late-relapse were excluded as well as thoraco-abdominal approaches. Preoperative imaging was reviewed by a urologist and a radiologist blinded to operative details.

RESULTS

Of 78 patients, 16 (20.5%) underwent MVS (caval and/or aortic replacement or reconstruction). On univariable analyses, transversal diameter, sagittal diameter, tumor volume, aorta- and cava-tumor contact angle, poor IGCCCG score, clinical stage III and preoperative positive markers were predictors of MVS (all p values ≤ 0.01). At multivariable analyses aorta- (cut-off 64°) and cava-tumor contact angle (cut-off 98°) and poor IGCCCG score represented the three most important predictors of MVS (all p values ≤ 0.05). The model constructed has a PPV 100%, NPV 87% and an accuracy of 88%.

CONCLUSIONS

Presence of aorta-tumor contact angle ≥ 64°, cava-tumor contact angle ≥ 98° and poor IGCCCG score identify correctly 9 out of 10 patients requiring MVS at the time of first PC-RPLND.

摘要

目的

评估预测接受化疗后腹膜后淋巴结清扫术(PC-RPLND)治疗睾丸癌患者行大血管手术(MVS)的概率。

方法

从 434 例患者的 504 例 RPLND 数据库中,确定了 78 例接受顺铂为基础的化疗后非精原细胞瘤生殖细胞癌且可获得术前 CT 扫描的患者接受 PC-RPLND。排除了第二次 PC-RPLND(再剂量)、挽救性 RPLND 或晚期复发的 RPLND 以及胸腹联合入路。术前影像学由泌尿科医生和放射科医生进行盲法评估。

结果

在 78 例患者中,16 例(20.5%)行 MVS(腔静脉和/或主动脉置换或重建)。单变量分析显示,横径、矢状径、肿瘤体积、主动脉和腔静脉肿瘤接触角、较差的 IGCCCG 评分、临床分期 III 期和术前阳性标志物是 MVS 的预测因素(所有 p 值均≤0.01)。多变量分析显示,主动脉(临界值 64°)和腔静脉肿瘤接触角(临界值 98°)以及较差的 IGCCCG 评分是 MVS 的三个最重要的预测因素(所有 p 值均≤0.05)。构建的模型具有 100%的阳性预测值、87%的阴性预测值和 88%的准确性。

结论

在首次 PC-RPLND 时,存在主动脉肿瘤接触角≥64°、腔静脉肿瘤接触角≥98°和较差的 IGCCCG 评分,可正确识别 90%的需要行 MVS 的患者。

相似文献

1
Preoperative clinical and radiographic predictors of major vascular surgery in patients with testicular cancer undergoing post-chemotherapy residual tumor resection (PC-RPLND).在接受化疗后残余肿瘤切除(PC-RPLND)的睾丸癌患者中,主要血管手术的术前临床和影像学预测因素。
World J Urol. 2022 Feb;40(2):349-354. doi: 10.1007/s00345-021-03870-8. Epub 2021 Nov 3.
2
Clinical and Radiographic Predictors of Great Vessel Resection or Reconstruction During Retroperitoneal Lymph Node Dissection for Testicular Cancer.睾丸癌腹膜后淋巴结清扫术中大血管切除或重建的临床及影像学预测因素
Urology. 2019 Jan;123:186-190. doi: 10.1016/j.urology.2018.08.028. Epub 2018 Sep 1.
3
Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients.腹腔镜化疗后腹膜后淋巴结清扫术可成为特定非精原细胞性生殖细胞肿瘤患者的标准选择。
J Endourol. 2016 Oct;30(10):1112-1119. doi: 10.1089/end.2016.0458.
4
Postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for seminoma: Limitations of surgical intervention after first-line chemotherapy.精原细胞瘤的化疗后腹膜后淋巴结清扫术(PC-RPLND):一线化疗后手术干预的局限性
Urol Oncol. 2023 Sep;41(9):394.e1-394.e6. doi: 10.1016/j.urolonc.2023.06.019. Epub 2023 Aug 4.
5
Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.辅助手术在接受化疗后腹膜后淋巴结清扫术的睾丸癌患者中的应用。
Ann Surg Oncol. 2012 Jul;19(7):2388-93. doi: 10.1245/s10434-012-2284-8. Epub 2012 Mar 7.
6
[Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].[化疗后腹膜后淋巴结清扫术的临床结果及预测睾丸晚期非精原细胞瘤腹膜后组织学情况]
Zhonghua Wai Ke Za Zhi. 2017 Aug 1;55(8):603-607. doi: 10.3760/cma.j.issn.0529-5815.2017.08.010.
7
Testicular Radiomics To Predict Pathology At Time of Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Tumor.基于睾丸影像组学预测非精原细胞瘤生殖细胞肿瘤化疗后腹膜后淋巴结清扫时的病理情况。
Clin Genitourin Cancer. 2024 Feb;22(1):33-37. doi: 10.1016/j.clgc.2023.07.004. Epub 2023 Jul 7.
8
Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection.晚期睾丸生殖细胞肿瘤化疗后腹膜后淋巴结清扫术:根治性或改良模板切除术。
Eur Urol. 2009 Jan;55(1):217-24. doi: 10.1016/j.eururo.2008.09.027. Epub 2008 Sep 24.
9
[Postchemotherapy residual tumour resection in complex metastatic sites of advanced testicular germ cell tumours].[晚期睾丸生殖细胞肿瘤复杂转移部位化疗后残留肿瘤切除术]
Urologe A. 2016 May;55(5):632-40. doi: 10.1007/s00120-016-0031-7.
10
Role of postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors.化疗后腹膜后淋巴结清扫术在晚期生殖细胞肿瘤中的作用。
Hematol Oncol Clin North Am. 2011 Jun;25(3):593-604, ix. doi: 10.1016/j.hoc.2011.03.002. Epub 2011 Apr 13.

引用本文的文献

1
Evaluating classification tools for the prediction of in-vitro microbial pyruvate yield from organic carbon sources.评估用于预测有机碳源体外微生物丙酮酸产率的分类工具。
PLoS One. 2024 Jul 11;19(7):e0306987. doi: 10.1371/journal.pone.0306987. eCollection 2024.
2
Rhabdomyosarcoma in Adults: De Novo or Conversion From Non-seminomas?成人横纹肌肉瘤:新发还是由非精原细胞瘤转化而来?
Cureus. 2024 Mar 3;16(3):e55449. doi: 10.7759/cureus.55449. eCollection 2024 Mar.
3
Post-chemotherapy robot-assisted retroperitoneal lymph node dissection for metastatic germ cell tumors: safety and perioperative outcomes.

本文引用的文献

1
Additional surgical procedures and perioperative morbidity in post-chemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer in two intermediate volume hospitals.两家中等规模医院中转移性睾丸癌化疗后腹膜后淋巴结清扫术的额外手术操作及围手术期发病率
World J Urol. 2021 Mar;39(3):839-846. doi: 10.1007/s00345-020-03229-5. Epub 2020 May 5.
2
Radiomics allows for detection of benign and malignant histopathology in patients with metastatic testicular germ cell tumors prior to post-chemotherapy retroperitoneal lymph node dissection.放射组学可在化疗后腹膜后淋巴结清扫术之前,检测转移性睾丸生殖细胞肿瘤患者的良性和恶性组织病理学。
Eur Radiol. 2020 Apr;30(4):2334-2345. doi: 10.1007/s00330-019-06495-z. Epub 2019 Dec 11.
3
化疗后机器人辅助腹膜后淋巴结清扫术治疗转移性生殖细胞肿瘤:安全性和围手术期结果。
World J Urol. 2023 Sep;41(9):2405-2411. doi: 10.1007/s00345-023-04536-3. Epub 2023 Jul 28.
4
Complete Vascular Replacement of the Infrarenal Inferior Vena Cava and Abdominal Aorta during Post-Chemotherapy Retroperitoneal Lymph Node Dissection for a Non-Seminomatous Germ Cell Tumor.在后化疗腹膜后淋巴结清扫期间为非精原细胞瘤生殖细胞肿瘤行肾下下腔静脉和腹主动脉完全血管置换。
Curr Oncol. 2023 Jun 4;30(6):5448-5455. doi: 10.3390/curroncol30060412.
5
Minimally invasive retroperitoneal lymph node dissection for men with testis cancer: a retrospective cohort study of safety and feasibility.经腹膜后微创淋巴结清扫术治疗睾丸癌男性患者:安全性和可行性的回顾性队列研究。
World J Urol. 2022 Jun;40(6):1505-1512. doi: 10.1007/s00345-022-03974-9. Epub 2022 Mar 13.
6
Special Issue on Testis Cancer.睾丸癌专题
World J Urol. 2022 Feb;40(2):305-306. doi: 10.1007/s00345-022-03957-w.
Preservation of Ejaculatory Function After Postchemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND) in Patients With Testicular Cancer: Template vs. Bilateral Resection.睾丸癌患者化疗后腹膜后淋巴结清扫术(PC-RPLND)后射精功能的保留:模板式清扫与双侧清扫对比
Front Surg. 2019 Jan 17;5:80. doi: 10.3389/fsurg.2018.00080. eCollection 2018.
4
Clinical and Radiographic Predictors of Great Vessel Resection or Reconstruction During Retroperitoneal Lymph Node Dissection for Testicular Cancer.睾丸癌腹膜后淋巴结清扫术中大血管切除或重建的临床及影像学预测因素
Urology. 2019 Jan;123:186-190. doi: 10.1016/j.urology.2018.08.028. Epub 2018 Sep 1.
5
Residual tumor resection (RTR).残余肿瘤切除(RTR)。
World J Urol. 2017 Aug;35(8):1185-1190. doi: 10.1007/s00345-016-1984-2. Epub 2016 Dec 21.
6
Surgical management of complex residual masses following systemic chemotherapy for metastatic testicular germ cell tumours.全身化疗治疗转移性睾丸生殖细胞肿瘤后复杂残留肿块的手术治疗。
Ann Oncol. 2017 Feb 1;28(2):362-367. doi: 10.1093/annonc/mdw605.
7
Residual tumor size and IGCCCG risk classification predict additional vascular procedures in patients with germ cell tumors and residual tumor resection: a multicenter analysis of the German Testicular Cancer Study Group.残余肿瘤大小和 IGCCCG 风险分类预测生殖细胞肿瘤患者在残余肿瘤切除术后需要进一步血管介入治疗:德国睾丸癌研究组的一项多中心分析。
Eur Urol. 2012 Feb;61(2):403-9. doi: 10.1016/j.eururo.2011.10.045. Epub 2011 Nov 7.
8
EAU guidelines on testicular cancer: 2011 update.EAU 睾丸癌指南:2011 年更新版。
Eur Urol. 2011 Aug;60(2):304-19. doi: 10.1016/j.eururo.2011.05.038. Epub 2011 May 25.
9
Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group.播散性非精原细胞性生殖细胞肿瘤一线化疗后的存活恶性细胞:预后因素及术后化疗的作用——一项国际研究组的结果
J Clin Oncol. 2001 May 15;19(10):2647-57. doi: 10.1200/JCO.2001.19.10.2647.
10
Vascular interventions during post-chemotherapy retroperitoneal lymph-node dissection for metastatic testis cancer.化疗后转移性睾丸癌腹膜后淋巴结清扫术中的血管介入治疗
Eur J Surg Oncol. 1998 Aug;24(4):292-7. doi: 10.1016/s0748-7983(98)80009-7.